Glycemic control superior with semaglutide 25 and 50 mg in type 2 diabetes

Once-daily semaglutide 25 mg or 50 mg is superior to 14 mg for glycemic control among adults with type 2 diabetes, according to a study published online June 25 in The Lancet.

Leave A Comment

Your email address will not be published. Required fields are marked *